Cellect Biotechnology Ltd. announced that Mr. Ronen Twito, the company's Chief Financial Officer and Deputy CEO, has resigned from his role to pursue other interests. The company's Board of Directors further announced the appointment of Mr. Eyal Leibovitz as the company CFO, effective as of January 1, 2017. Mr. Twito will continue working with the new CFO during his notice period of four months.

Mr. Leibovitz has over 27 years of experience in senior management, finance, IR, M&A and business development in international pharma and biotech companies. Among his many achievements, he led Kamada to a successful large scale funds raising (including PIPE round, public rights offering, venture lending and public convertible debt) and led the sale of N-trig to Microsoft. In all companies he held full responsibility of all financial reporting, budget control, financial planning, strategic negotiations, IR/PR, legal proceedings, operations and HR.

Mr. Leibovitz holds a BBA degree from the City University of New York, majoring in Finance.